Improving the chance of recovery from the short- and long-term consequences of XXXX .

@entity1 @entity717 @entity308 @entity102
@entity308 ( @entity308 ) is a common, @entity102 that requires long-term management. Although effective treatments are available, @entity308 frequently remains undiagnosed. Furthermore, once recognized, treatment duration and dosage are often inadequate and adherence to medication is often poor. However, adequate acute phase treatment of @entity308 is essential to reduce symptomatology, and improve quality of life and the clinical course. After remission, treatment should be continued for 4-9 months to consolidate the remission and prevent relapse. For @entity1 who do not respond adequately to their initial antidepressant therapy, switching or augmentation of therapy may be necessary. Many @entity1 suffer residual symptomatology, even when classified as being in remission. In addition to the suffering and impairment that this causes, residual symptomatology is associated with a high rate of relapse. Clinicians should strive to achieve asymptomatic recovery both in terms of core symptomatology and @entity717 . This requires appropriate treatment at therapeutic doses for a sufficient duration; education and support to promote @entity1 compliance with treatment; and regular monitoring and prompt intervention for @entity1 with symptoms that persist even at subsyndromal levels. In conclusion, there remains considerable scope for improving the identification, treatment and management of @entity1 with @entity308 .
